BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 23700696)

  • 1. The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA trial.
    Amundsen CL; Richter HE; Menefee S; Vasavada S; Rahn DD; Kenton K; Harvie HS; Wallace D; Meikle S
    Contemp Clin Trials; 2014 Mar; 37(2):272-83. PubMed ID: 24486637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Overactive bladder].
    Golsong J
    MMW Fortschr Med; 2013 Apr; 155(6):44. PubMed ID: 23700696
    [No Abstract]   [Full Text] [Related]  

  • 4. [Not Available].
    Perucchini D; Betschart C; Fink D; Scheiner DA
    Praxis (Bern 1994); 2017 Jan; 106(1):37-44. PubMed ID: 28055318
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urinary incontinence: what's new in therapy?].
    Becher KF; Sieber CC
    Dtsch Med Wochenschr; 2015 Feb; 140(3):164-7. PubMed ID: 25658400
    [No Abstract]   [Full Text] [Related]  

  • 6. Overactive Bladder.
    White N; Iglesia CB
    Obstet Gynecol Clin North Am; 2016 Mar; 43(1):59-68. PubMed ID: 26880508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice. Idiopathic urgency urinary incontinence.
    Nygaard I
    N Engl J Med; 2010 Sep; 363(12):1156-62. PubMed ID: 20843250
    [No Abstract]   [Full Text] [Related]  

  • 8. The management of overactive bladder syndrome.
    Marinkovic SP; Rovner ES; Moldwin RM; Stanton SL; Gillen LM; Marinkovic CM
    BMJ; 2012 Apr; 344():e2365. PubMed ID: 22511208
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.